O-RAN-ALLIANCE-E.V.
As of January 2021, the O-RAN ALLIANCE welcomes LG U+ as its 28th operator member. With strong support by its expanding number of contributors, the alliance now counts more than 260 companies from around the globe, building a foundation and unifying the Radio Access Networks (RAN) industry towards open, intelligent, virtualized and fully interoperable RAN solutions.
O-RAN Open Summit (Virtual) Complements the O-RAN Demos at MWC Shanghai 2021
For latest updates on the evolution of open RAN, the O-RAN ALLIANCE invites interested industry participants to the O-RAN Open Summit . This compact virtual event will open with operator executives delivering a summary of O-RAN’s progress and developments. Subsequent keynotes and panel discussions with major O-RAN players will summarize the achievements and next steps in the O-RAN specification effort, testing and integration, and delivery of open software for the RAN.
The O-RAN Open Summit virtual event is scheduled for February 25, 2021 from 9:00-11:00pm China Standard Time (8:00-10:00am EST, 14:00-16:00 CET). For more information and to join the summit free of charge, please visit our website .
O-RAN Demonstrations at MWC Shanghai 2021 and at the O-RAN Virtual Showcase
Two O-RAN demonstrations are planned to be presented at the MWC Shanghai 2021:
- Sageran is demonstrating a complete O-RAN white-box small cell solution based on an x86 platform with an FPGA Accelerator card that showcases a stand-alone end-to-end use case using white box hardware for an indoor cell which supports MIMO with 4T4R. The demo is hosted at MWC Shanghai 2021 by Sageran, booth N2.C114 , as well as at the O-RAN Virtual Exhibition .
- VIAVI and Rohde & Schwarz are jointly demonstrating validation of open fronthaul performance. As network operators adopt disaggregated, multi-vendor networks, rigorous testing of performance and interoperability must accompany conformance testing. This demo showcases generation and delivery of typical standards based testcase IQ data to the O-RU utilizing the Lower Layer Split Option 7.2x fronthaul interface with the VIAVI TM500 O-RU Tester. Moreover, uplink and downlink fronthaul logs are captured, and RF signal generation and capture are performed using the Rohde & Schwarz VSG and VSA hardware with VSE Software for RF and IQ signal analysis. Testcase workflow is simplified for the end user utilizing the VIAVI O-RU Test Manager, providing a single point of test control. The demo is hosted at MWC Shanghai 2021 by VIAVI Solutions, booth N1.B137 , as well as at the O-RAN Virtual Exhibition .
5 more virtual demos for MWC Shanghai 2021 have enriched the O-RAN Virtual Exhibition :
- ITRI is demonstrating traffic steering xApps and Near-Real-Time Radio Intelligent Controller platform utilizing E2 procedures to monitor cell and UE metrics generated by RAN simulator and to offload some UE to neighbor cells such that the A1 policy is guaranteed.
- NVIDIA and VMWare are jointly demonstrating PoC of Aerial 5G gNB Layer-1 orchestration on VMWare telco cloud platform. This demo showcases NVIDIA Aerial SDK as cloud native function, with docker containers and Kubernetes manifests. Aerial cuBB onboarded to VMWare telco cloud platform offers service agility, operational efficiency and reduced CAPEX/OPEX through MANO.
- Viettel is demonstrating an end-to-end-solution based on Intel server (Xeon-D) with NIC (XXV710-DA2T) that is integrated with an outdoor micro O-RU via an Open Fronthaul Interface. The base station connects with EPC and Viettel’s eNB perform a complete NSA (Option 3X) white-box base station solution and ready for Commercial Deployment. The integrated system is verified using a commercial UE through the attach and speed test.
- Altiostar has teamed up with Airtel and NEC to demonstrate interoperability testing and integration of massive MIMO radio units (O-RU) and virtualized distributed units (O-DU) running on commercial-off-the-shelf (COTS) servers. The demonstration features a commercial end-to-end Open Fronthaul interface based on O-RAN specifications.
- Parallel Wireless is demonstrating 2G, 3G, 4G and 5G O-RAN based macro Open RAN to expand and modernize cellular networks with reduced TCO & simplified maintenance. It’s been proven in rural in 50+ networks globally and is now scalable for urban 2G 3G 4G while unleashing the full 5G potential.
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of more than 260 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN standards will enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks will at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations. For more information please visit www.o-ran.org .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210218006088/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom